Stay updated with breaking news from Kenneth Saag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At month 12, response rate was significantly higher in patients receiving pegloticase and methotrexate when compared with concomitant placebo.
While praising CMS’ 2023 Medicare Physician Fee Schedule for offering more flexibility, the American College of Rheumatology has submitted comments of concern over proposed reimbursement cuts to critical rheumatology services.In a comment letter to CMS dated Sept. 6, ACR stated it had concerns regarding a proposed 4.4% decrease — from $34.61 to $33.08 — to the calendar year 2023
Women of childbearing age report losing access to the arthritis medication methotrexate in states with abortion bans after the Supreme Court ruling.
Patients are reporting they are being denied medication they need for care since Roe v. Wade was overturned.
Phil Walter/Getty Images(NEW YORK) -- The Department of Health and Human Services announced it is investigating reports of women being denied vital medication